Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction | Zendy

Leandro Rocha Messias | Zendy; Aryanne Guimarães Ferreira | Zendy; Sandra Marina Ribeiro de Miranda | Zendy; José Antônio Caldas Teixeira | Zendy; Jader Cunha de Azevedo | Zendy; Ana Messias | Zendy; Elisabeth Maróstica | Zendy; Cláudio Tinoco Mesquita | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction

Author(s) -

Leandro Rocha Messias,

Aryanne Guimarães Ferreira,

Sandra Marina Ribeiro de Miranda,

José Antônio Caldas Teixeira,

Jader Cunha de Azevedo,

Ana Messias,

Elisabeth Maróstica,

Cláudio Tinoco Mesquita

Publication year - 2016

Publication title -

arquivos brasileiros de cardiologia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.4

H-Index - 53

eISSN - 1678-4170

pISSN - 0066-782X

DOI - 10.5935/abc.20160046

Subject(s) - medicine , nebivolol , ejection fraction , cardiology , heart rate , heart failure , blood pressure , hemodynamics

More than 50% of the patients with heart failure have normal ejection fraction (HFNEF). Iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy and cardiopulmonary exercise test (CPET) are prognostic markers in HFNEF. Nebivolol is a beta-blocker with vasodilating properties.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research